Wassim Choucair is a Cardiology physician. OpenAlex indexes 15 publications with 1,498 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
8122 Datapoint Dr
Ste 120
San Antonio, TX 782293272
Telephone
210-998-6900Provider last certified this registry record 22 Aug 2022.
Industry payments
40 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year202524 payments
- PFIZER INC.Program year202516 payments
- Impulse Dynamics (USA) Inc.Program year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
75.1%Beta blocker25.7%Metoprolol Succinate52%Carvedilol14%Nebivolol Hcl12%Propranolol Hcl Er10%Metoprolol Tartrate7%Sotalol3%Propranolol Hcl1%Atenolol1%Part D<11 patientsAngiotensin receptor blocker (ARB)10%Olmesartan Medoxomil33%Losartan Potassium29%Olmesartan-Hydrochlorothiazide22%Valsartan6%Losartan-Hydrochlorothiazide5%Valsartan-Hydrochlorothiazide5%Part D<11 patients+ 15 more classes in this area
Blood & clotting
14.1%Factor Xa inhibitor10.6%Eliquis55%Xarelto45%Part D≥65 patientsP2Y12 inhibitor3.3%Clopidogrel91%Brilinta9%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
6.7%SGLT2 inhibitor3.5%Jardiance85%Farxiga15%Part D<11 patientsPotassium supplement1.3%Potassium Chloride100%Part D≥28 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT)
The American Journal of Cardiology
2016 - Clinical Benefits of Remote Versus Transtelephonic Monitoring of Implanted Pacemakers
Journal of the American College of Cardiology
2009
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”